University of Michigan: $2.38M to Test Nano-Engineered Brain Cancer Treatment in Mice
June 16, 2022
June 16, 2022
ANN ARBOR, Michigan, June 16 (TNSres) -- The University of Michigan issued the following news release:
* * *
A protein that crosses the blood-brain barrier carries a drug that kills tumor cells and another that activates the immune system
* * *
A new nanomedicine that crosses the blood-brain barrier, engages the immune system and kills cancer cells may offer hope for treating the most aggressive form of brain cancer, glioblastoma.
. . .
* * *
A protein that crosses the blood-brain barrier carries a drug that kills tumor cells and another that activates the immune system
* * *
A new nanomedicine that crosses the blood-brain barrier, engages the immune system and kills cancer cells may offer hope for treating the most aggressive form of brain cancer, glioblastoma.
. . .